Efficacy and Safety of Pre-Endoscopy Regimens for Mucosal Visualization During Sedated Esophagogastro-duodenoscopy: A Randomized Controlled Trial.

IF 0.5 Q3 MEDICINE, GENERAL & INTERNAL
Acta medica Indonesiana Pub Date : 2026-01-01
Fauzi Yusuf, Azzaki Abubakar, Desi Maghfirah
{"title":"Efficacy and Safety of Pre-Endoscopy Regimens for Mucosal Visualization During Sedated Esophagogastro-duodenoscopy: A Randomized Controlled Trial.","authors":"Fauzi Yusuf, Azzaki Abubakar, Desi Maghfirah","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Optimal mucosal visibility during esophagogastroduodenoscopy (EGD) is critical for diagnostic accuracy but is often impaired by the presence of mucus and bubbles. This study aimed to compare the efficacy and safety of four premedication regimens for mucosal visualization during sedated EGD.</p><p><strong>Methods: </strong>A double-blind randomized controlled trial was conducted at the Endoscopy Unit of Dr. Zainoel Abidin General Hospital, Banda Aceh, Indonesia, from January to December 2024. Patients scheduled for elective diagnostic EGD were randomly assigned to: Group 1 (simethicone 40 mg at 30 minutes before the procedure), Group 2 (simethicone 40 mg + 100 mL 5% sodium bicarbonate at 2 hours), Group 3 (simethicone 40 mg + N-acetylcysteine 600 mg in 100 mL water at 2 hours), or Group 4 (all three agents at 2 hours). Primary outcomes were mucosal visibility (6-site, 3-point scoring system with lower scores indicating superior mucosal visibility); procedural metrics (irrigation volume and duration); and safety (the lowest recorded SpO₂%). Data were analyzed using ANOVA or Kruskal-Wallis for continuous variables, and Chi-square or Fisher's exact test for categorical variables, with post hoc testing as applicable.</p><p><strong>Results: </strong>A total of 168 patients were randomized into four groups (n=42 each). Groups 3 and 4 showed superior mucosal visibility compared to Groups 1 and 2 (p=0.004), with no significant difference between Groups 3 and 4. Irrigation volume differed significantly (p=0.018), lowest in Group 4. Group 3 had the shortest procedure time (3.1 ± 1.2 minutes), significantly more efficient than Groups 1 and 2, but similar to Group 4. Oxygen saturation was slightly lower in Group 3 (p<0.005), though all groups remained within safe clinical limits.</p><p><strong>Conclusions: </strong>Simethicone and N-acetylcysteine given two hours before endoscopy effectively enhanced mucosal visibility and procedural efficiency without compromising safety, offering a practical alternative to more complex regimens.</p>","PeriodicalId":6889,"journal":{"name":"Acta medica Indonesiana","volume":"58 1","pages":"5-14"},"PeriodicalIF":0.5000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta medica Indonesiana","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Optimal mucosal visibility during esophagogastroduodenoscopy (EGD) is critical for diagnostic accuracy but is often impaired by the presence of mucus and bubbles. This study aimed to compare the efficacy and safety of four premedication regimens for mucosal visualization during sedated EGD.

Methods: A double-blind randomized controlled trial was conducted at the Endoscopy Unit of Dr. Zainoel Abidin General Hospital, Banda Aceh, Indonesia, from January to December 2024. Patients scheduled for elective diagnostic EGD were randomly assigned to: Group 1 (simethicone 40 mg at 30 minutes before the procedure), Group 2 (simethicone 40 mg + 100 mL 5% sodium bicarbonate at 2 hours), Group 3 (simethicone 40 mg + N-acetylcysteine 600 mg in 100 mL water at 2 hours), or Group 4 (all three agents at 2 hours). Primary outcomes were mucosal visibility (6-site, 3-point scoring system with lower scores indicating superior mucosal visibility); procedural metrics (irrigation volume and duration); and safety (the lowest recorded SpO₂%). Data were analyzed using ANOVA or Kruskal-Wallis for continuous variables, and Chi-square or Fisher's exact test for categorical variables, with post hoc testing as applicable.

Results: A total of 168 patients were randomized into four groups (n=42 each). Groups 3 and 4 showed superior mucosal visibility compared to Groups 1 and 2 (p=0.004), with no significant difference between Groups 3 and 4. Irrigation volume differed significantly (p=0.018), lowest in Group 4. Group 3 had the shortest procedure time (3.1 ± 1.2 minutes), significantly more efficient than Groups 1 and 2, but similar to Group 4. Oxygen saturation was slightly lower in Group 3 (p<0.005), though all groups remained within safe clinical limits.

Conclusions: Simethicone and N-acetylcysteine given two hours before endoscopy effectively enhanced mucosal visibility and procedural efficiency without compromising safety, offering a practical alternative to more complex regimens.

在镇静的食管胃十二指肠镜检查中,内镜前粘膜显像方案的有效性和安全性:一项随机对照试验。
背景:食管胃十二指肠镜检查(EGD)时最佳粘膜可见性对诊断准确性至关重要,但通常因粘液和气泡的存在而受损。本研究旨在比较四种药物前方案在镇静EGD期间粘膜显像的有效性和安全性。方法:于2024年1月至12月在印度尼西亚班达亚齐Zainoel Abidin医生总医院内窥镜科进行双盲随机对照试验。计划进行选择性诊断性EGD的患者被随机分配到:1组(西甲硅氧烷40 mg在手术前30分钟),2组(西甲硅氧烷40 mg + 100 mL 5%碳酸氢钠,在手术前2小时),3组(西甲硅氧烷40 mg + n -乙酰半胱氨酸600 mg,在100 mL水中,在手术前2小时),或4组(所有三种药物在2小时)。主要结局是粘膜可见性(6个部位,3分评分系统,分数越低表明粘膜可见性越好);程序指标(灌溉量和持续时间);安全(有史以来最低的SpO₂%)。对连续变量使用ANOVA或Kruskal-Wallis进行数据分析,对分类变量使用卡方或Fisher精确检验,并适用事后检验。结果:168例患者随机分为4组,每组42例。与1、2组相比,3、4组粘膜可见性较好(p=0.004), 3、4组间差异无统计学意义。灌水量差异有统计学意义(p=0.018),以第4组最低。3组手术时间最短(3.1 ± 1.2 min),效率显著高于1、2组,但与4组相似。结论:内窥镜检查前2小时给予西甲硅氧烷和n -乙酰半胱氨酸可有效提高粘膜可视性和手术效率,且不影响安全性,为更复杂的方案提供了实用的替代方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acta medica Indonesiana
Acta medica Indonesiana MEDICINE, GENERAL & INTERNAL-
CiteScore
2.30
自引率
0.00%
发文量
61
审稿时长
12 weeks
期刊介绍: Acta Medica Indonesiana – The Indonesian Journal of Internal Medicine is an open accessed online journal and comprehensive peer-reviewed medical journal published by the Indonesian Society of Internal Medicine since 1968. Our main mission is to encourage the novel and important science in the clinical area in internal medicine. We welcome authors for original articles (research), review articles, interesting case reports, special articles, clinical practices, and medical illustrations that focus on the clinical area of internal medicine. Subjects suitable for publication include, but are not limited to the following fields of: -Allergy and immunology -Emergency medicine -Cancer and stem cells -Cardiovascular -Endocrinology and Metabolism -Gastroenterology -Gerontology -Hematology -Hepatology -Tropical and Infectious Disease -Virology -Internal medicine -Psychosomatic -Pulmonology -Rheumatology -Renal and Hypertension -Thyroid
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书